ABL Texcell Diagnostics is acquiring IntegraGen's genomics and bioinformatics business and assets under an Évry Commercial Court ruling, as IntegraGen enters judicial liquidation.
We only link to sources you can read without a subscription. How we check.
Chinese technology group Midea has completed its acquisition of a majority stake in Esaote, the Genoa-based medical imaging company. Esaote will join Midea's Healthcare Division but keep operating as an independent global medical equipment company. Its R&D and production sites in Italy and the Netherlands remain in place.
Sopris Capital completed its purchase of AI imaging orchestration firm Blackford Analysis from Bayer and plans to combine it with portfolio company Azra AI.
Valerio Therapeutics completed its purchase of 100% of Etherna Immunotherapies NV, building an integrated targeted RNA platform.
Viatris agreed to buy Pacira BioSciences in a roughly $1.7B buyout. The deal brings in post-surgical pain drug Exparel and knee osteoarthritis therapy Zilretta, which together booked nearly $700M in 2025. Leerink expects the deal to be immediately accretive to revenue.